What is OPRX's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.16B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for OPRX?

P/E (TTM) is 35.33 and 52-week range is $4.54 to $22.25 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s OPRX figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for OPRX?

The company profile lists revenue (TTM) near $99M, net income (TTM) near $5M, EPS (TTM) near $0.24 when available from the market-data feed. Figures are informational and may lag live markets.

Where is OptimizeRx Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Waltham, Massachusetts, US, 18.8M shares outstanding, ISIN US68401U2042 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Free AI scores & summaries library

OptimizeRx Corp

$OPRX

Health Care · Health Care Technology

IR Run Scenarios

$9.04

+3.43%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

Employees

104

Website

www.optimizerx.com/

IPO

2005-05-18

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)